跳到主要内容
Rallybid

筹划中

PME for Tissue and Cell Management System

King's College Hospital NHS Foundation Trust已就“PME for Tissue and Cell Management System”发布此招标,现已不再接受新的投标。

此招标已不再接受新的投标。 类似的进行中招标

用通俗的话说,这项招标是什么?

此公告尚未翻译,以原文语言显示。

同类招标的过往中标记录说明了什么?

  • 同类招标平均每项约有 2.2 份投标(47 项中标记录载有数目)。
  • 半数同类合同的中标金额介于 £264,913 至 £600,000,中位数为 £382,757。

根据过去 36 个月 315 项中标记录:相同工种、相同地区、金额相近。可信程度:高。以上仅反映过往情况,并非预测结果。 中标数据

谁赢得了这项招标,金额是多少?

此招标尚未公布中标结果。

公告全文

原文(English)

PME for Tissue and Cell Management System

King's College Hospital NHS Foundation Trust ("the Trust") is carrying out preliminary market engagement under the Procurement Act 2023 to understand the solutions available for a tissue and cell management system supporting its stem cell transplantation and cellular therapy laboratory services. The Trust currently uses a commercial off-the-shelf tissue and cell management system, in live use since 2023. The infrastructure on which it runs reaches end of support in January 2027, and the Trust is assessing its options for continuity of service from 2027. These include upgrading or migrating the existing solution and adopting an alternative solution. The purpose of this engagement is to establish which providers of this type of system exist in the market, and their level of interest, to help the Trust decide on the most appropriate route to market and timescales. The outcome will inform the Trust's requirements, options appraisal and business case, and the Trust anticipates that it will be followed by a formal procurement. The Trust is seeking solutions that provide end-to-end management and traceability of cellular therapy products, from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. The solution will need to support: • labelling and traceability in line with ICCBBA ISBT 128 standards; • a complete and secure audit trail; • quality management, including deviations and non-conformances; • inventory and storage location management; and • reporting. The solution will need to enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards. It should also meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems) and 21 CFR Part 11, and comply with MHRA data integrity expectations. Supplier support for installation, operational and performance qualification (IQ/OQ/PQ) will be required before go-live, together with an approach to upgrades after go-live that controls system changes and minimises the revalidation burden. The Trust is particularly interested in understanding the following: • which suppliers offer a solution that can meet these requirements, and any areas that would not be met; • deployment models (on-premise, supplier-hosted or cloud/SaaS), including whether solutions can be delivered on Microsoft-based infrastructure (Windows Server and Microsoft SQL Server) or as a fully hosted service; • whether suppliers have live interfaces with Epic or other electronic patient record systems in the UK; • typical implementation timescales, including validation and data migration; • indicative costs, to help inform the Trust's Outline Business Case; • whether the solution is available through an NHS England-approved framework agreement or dynamic market; and • whether suppliers would expect to take part in a competitive procurement, and their views on the Trust's proposed approach and indicative timescales.

通过邮件接收这些招标

每天一封邮件,列出你所选行业和地区的新招标。无需账户或密码。

我们会先通过邮件向你发送确认链接。在你使用链接之前,不会发送任何其他内容。 隐私声明

快速解答

这项招标什么时候截止?

公告没有注明截止日期。请查看采购方的门户网站。

这份合同价值多少?

采购方估计金额为£450,000。

采购方是谁?

采购方是King's College Hospital NHS Foundation Trust。

同类招标通常有多少企业投标?

同类招标平均每项约有 2.2 份投标(47 项中标记录载有数目)。 根据过去 36 个月 315 项中标记录:相同工种、相同地区、金额相近。可信程度:高。以上仅反映过往情况,并非预测结果。

类似的进行中招标